Form 4: Edwards Lifesciences Executive Reports Stock Transactions
SEC Form 4 Filing
Jean-Luc M. Lemercier, a CVP at Edwards Lifesciences, reports the vesting and subsequent disposal of shares related to performance rights.
Summary
- On May 3, 2024, Jean-Luc M. Lemercier disposed of 37 shares of common stock at a price of $85.06.
- On May 4, 2024, 4,157 shares of common stock were acquired through the vesting of performance rights.
- Also on May 4, 2024, 4,157 performance rights vested and were converted into common stock.
- On May 6, 2024, 259 shares of common stock were disposed of at a price of $85.25.
- Following these transactions, Lemercier directly owns 177,709.8055 shares of Edwards Lifesciences common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing primarily reflects routine transactions related to vested performance rights. The vesting itself suggests the company met certain performance criteria, which is mildly positive.
Positives
- The vesting of performance rights indicates that performance targets were met, suggesting positive performance for the company.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking to understand management's perspective on the company's stock.
Stakeholder Impact
- The vesting of performance rights aligns management's interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/04/2021 | Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. |
| 05/01/2024 | The Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024. |
| 05/03/2024 | Disposal of 37 shares of common stock. |
| 05/04/2024 | Vesting of 4,157 performance rights and acquisition of 4,157 shares of common stock. |
| 05/06/2024 | Disposal of 259 shares of common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.